Hereditary Coproporphyria News and Research

RSS
Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Researchers reveal basis for hereditary coproporphyria

Researchers reveal basis for hereditary coproporphyria